Cyprus is grappling with critically low supplies of injectable diabetes medications due to a global shortage.
\nThis shortage stems from a surge in the use of these drugs for weight loss, often by those without diabetes.
\nThe increased, and frequently unnecessary, administration of these medications has overwhelmed pharmaceutical companies\u2019 production capacity, hindering their ability to fulfil orders for patients with genuine medical needs.
\nThe Health Insurance Organisation (HIO) has acknowledged the issue for several weeks, notifying doctors and patients that none of the usual suppliers participated in the latest tender. Consequently, the General Healthcare System (GHS) is currently unable to provide these medications to its beneficiaries.
\nThe HIO is actively seeking alternative sources to secure these vital medications for GHS-covered diabetic patients.
\nIn response to the crisis, the Cyprus Patients\u2019 Federation (CyFPA) urges Cypriot doctors to act responsibly when prescribing these medications. They emphasise that prescriptions, both within and outside the GHS system, should be reserved for diabetic patients and those with legitimate medical needs.
\nCyFPA also appeals to the public to understand the urgency of prioritizing these medications for those who truly require them and to avoid pressuring doctors for weight-loss purposes.
\nCyFPA further calls on pharmaceutical companies to engage positively with the HIO to ensure these medications remain available within the GHS framework.
\nDr. Konstantinos Tsioutis, President of CyFPA\u2019s Scientific Advisory Committee, highlighted the crucial role these medications play in managing diabetes, particularly for patients with uncontrolled conditions, obesity-related diabetes, or an increased risk of cardiovascular problems.
\nHowever, he expressed concern that the widespread adoption and use of these drugs have led to critical global shortages.
\n\u201cThis situation,\u201d Tsioutis stated, \u201chas created a significant challenge for healthcare systems and pharmaceutical companies, putting access to these vital medications at risk for those who need them most. We are witnessing this firsthand in Cyprus, where diabetics who rely on these drugs are unable to obtain them due to the dramatic increase in prescriptions for non-medical purposes.\u201d
\nTsioutis concluded by urging the medical community and the public to collaborate in ensuring these medications are only dispensed to patients with a valid medical justification, as outlined in the product information until the global supply chain recovers.injectable diabetes medications. shortage of injectable diabetes medications, weight loss, pharmaceutical companies<\/p>\n","protected":false},"excerpt":{"rendered":"
Cyprus is facing a shortage of injectable diabetes medications due to increased use for weight loss, overwhelming pharmaceutical production capacity. The Health Insurance Organisation is seeking alternative sources to provide medications for diabetic patients. The Cyprus Patients\u2019 Federation urges doctors to prescribe responsibly and for the public to prioritize these medications for those with genuine medical needs. Dr. Konstantinos Tsioutis emphasizes the importance of these medications for managing diabetes and expresses concern over critical global shortages caused by unnecessary prescriptions. Tsioutis calls for collaboration to ensure medications are only given to patients with valid medical justifications until the global supply chain improves.<\/p>\n","protected":false},"author":5,"featured_media":11954,"comment_status":"open","ping_status":"closed","sticky":false,"template":"Default","format":"standard","meta":{"_acf_changed":false,"footnotes":""},"categories":[1],"tags":[6552,9913,6595,2858,5702,2460,33,5732,5255,3,946,263,8314,725,210,8659,4134,793,8835,1823,7818,148,5527,3168,4941,6535,10150,4843,8240,8872,8257,4054,7876,10148,8410,6386,4472,1565,114,10149,6305],"class_list":["post-11953","post","type-post","status-publish","format-standard","has-post-thumbnail","hentry","category-other","tag-access","tag-adoption","tag-capacity","tag-collaboration","tag-committee","tag-community","tag-companies","tag-conditions","tag-crisis","tag-cyprus","tag-doctors","tag-drugs","tag-framework","tag-ghs","tag-health","tag-health-insurance","tag-health-insurance-organisation","tag-healthcare","tag-healthcare-system","tag-increase","tag-insurance","tag-local","tag-loss","tag-obesity","tag-organisation","tag-patients","tag-pharmaceutical-companies","tag-president","tag-problems","tag-production","tag-response","tag-risk","tag-shortage","tag-shortage-of-injectable-diabetes-medications","tag-shortages","tag-situation","tag-supply-chain","tag-surge","tag-top-news","tag-weight-loss","tag-who"],"acf":{"keyphrase":"","keywords":"","sourceimg":"","country-category":""},"yoast_head":"\n